UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea’s annual healthcare conference to go online only
by Kim Chan-hyuk
2020-09-02 11:05
T&R Biofab gains sales rights of pluripotent stem cell-derived cardiomyocyte
by Shim Hyun-tai
2020-09-01 14:13
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
by Shim Hyun-tai
2020-08-26 17:17
Drugmakers in active open innovation with startups
by Kim Chan-hyuk
2020-08-25 11:51
Samsung Bioepis wins European nod for Avastin biosimilar
by Lee Han-soo
2020-08-21 11:32
라인
Resurge of Covid-19 cases throw cold water on biotech events
by Kim Chan-hyuk
2020-08-18 15:37
Celltrion to start P1 trial of Prolia biosimilar
by Lee Han-soo
2020-08-14 15:32
Celltrion Healthcare posts record-breaking Q2 profit
by Lee Han-soo
2020-08-13 16:34
Organoid developed as research model for gut microbiome
by Shim Hyun-tai
2020-08-11 17:48
Samsung Biologics to invest ₩1.7 trillion to build world’s largest plant
by Lee Han-soo
2020-08-11 15:11
라인
Celltrion, Incheon to create global bio innovation cluster
by Shim Hyun-tai
2020-08-05 18:03
Samsung Biologics unveils proprietary cell line tech -- S-CHOice
by Lee Han-soo
2020-08-05 15:23
Biotech firms seek IPO amid bubble concerns
by Kim Chan-hyuk
2020-08-05 15:23
Celltrion to start P1 trial of Covid-19 treatment in UK
by Lee Han-soo
2020-07-30 16:17
Samsung Bioepis' 1H biosimilar sales in EU top $390 million
by Lee Han-soo
2020-07-23 17:57
라인
Celltrion’s Covid-19 diagnostic kit gets CE certification
by Lee Han-soo
2020-07-17 15:39
Chunlab, Boryung to launch ‘Gut-scanning’ microbiome checkup service
by Shim Hyun-tai
2020-07-13 15:47
US-based Psomagen stocks shot up on 1st day of Kosdaq listing
by Kim Chan-hyuk
2020-07-13 14:56
Will Biogen win FDA nod for Alzheimer’s drug aducanumab?
by Kim Yun-mi
2020-07-09 16:06
Biotech firms offer bonus shares to increase liquidity
by Kim Chan-hyuk
2020-07-09 14:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top